Bellevue Healthcare Strategy U2 EUR

Reference Data

ISIN LU2334253387
Valor Number
Bloomberg Global ID
Fund Name Bellevue Healthcare Strategy U2 EUR
Fund Provider Bellevue Asset Management AG Zürich, Switzerland
Phone: +41 44 267 67 00
E-Mail: info@bellevue.ch
Web: www.bellevue.ch
Fund Provider Bellevue Asset Management AG
Representative in Switzerland Waystone Fund Services (Switzerland) SA
Lausanne
Phone: 0041213111781
Distributor(s) Bank am Bellevue AG
Küsnacht
Phone: +41 44 267 67 67
Asset Class Equities
EFC Category
Distribution Policy Accumulation
Home Country Luxembourg
Issuing Condition Combination of issuing commission charged by the fund management company and transaction fee charged by the fund
Redemption Condition Combination of redemption commission charged by the fund management company and transaction fee charged by the fund
Investment Strategy *** The Sub-fund is an actively managed equity fund. It is based on the Bellevue Healthcare Strategy that has been in existence since 2007. The investment objective of the sub-fund is to achieve long-term capital growth by investing at least two-thirds of the net assets of Bellevue Healthcare Strategy in a portfolio of carefully chosen shares and other equity securities of companies in the healthcare industry, or companies whose main activity consists of holding shares in such companies or financing such companies and who have their registered office or carry out the majority of their economic activity in recognised countries.
Peculiarities

Fund Prices

Current Price * 122.23 EUR 02.04.2025
Previous Price * 122.62 EUR 01.04.2025
52 Week High * 133.46 EUR 30.08.2024
52 Week Low * 120.42 EUR 19.04.2024
NAV * 122.23 EUR 02.04.2025
Issue Price *
Redemption Price *
Closing Price *
Indicative Minimum Price
Fund Assets *** 305,020,734
Unit/Share Assets ***
Trading Information SIX

Performance

YTD Performance -3.08% 30.12.2024
02.04.2025
YTD Performance (in CHF) -1.62% 30.12.2024
02.04.2025
1 month -5.15% 03.03.2025
02.04.2025
3 months -4.05% 02.01.2025
02.04.2025
6 months -5.72% 02.10.2024
02.04.2025
1 year -1.34% 02.04.2024
02.04.2025
2 years +3.88% 03.04.2023
02.04.2025
3 years -8.73% 04.04.2022
02.04.2025
5 years -4.70% 15.06.2021
02.04.2025

Tax Data

Equity Participation Rate in %
Share of Total Fund Assets in %
Real Estate Rate in %
ADDI
ADDI Date

Top 10 Holdings ***

Penumbra Inc 3.73%
Boston Scientific Corp 3.61%
Eli Lilly and Co 3.50%
Intuitive Surgical Inc 3.25%
Cencora Inc 3.13%
Stryker Corp 3.07%
Amgen Inc 3.05%
Encompass Health Corp 3.01%
Molina Healthcare Inc 3.00%
AstraZeneca PLC 2.97%
Last data update 28.02.2025

Cost / Risk

TER 0.92%
TER date 29.01.2021
Performance Fee ***
PTR
Max. Management Fee *** 0.60%
Ongoing Charges *** 0.93%
SRRI ***
SRRI date *** 31.03.2025

Breakdowns

Countries ***

Stock Sectors ***


* NAV / Issue Price exclusive commissions, for listed funds NAV or closing price
** Calculation of interim profit followed § 9 Satz 2 InvStG
*** Data source: Morningstar (Data is based on the rescaled long position of the holdings)